A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy
Clinical trial NCT05511051 · UNKNOWN
Trial details
- NCT number
- NCT05511051
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2024-08-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.